O'Kane Kieran — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

O'Kane Kieran is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $16K.

Profile

O'Kane Kieran

Kieran O'Kane is the Chief Commercial Officer at Biodesix Inc, a company specializing in diagnostic solutions for lung disease. He has been involved in the company's operations as it provides diagnostic testing services and develops companion diagnostics.

RoleInsider
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-02-24BDSXBIODESIX INCS — Open-market sale535$12.78$7K
2026-02-24BDSXBIODESIX INCM — Option exercise1.5K—
2026-02-11BDSXBIODESIX INCS — Open-market sale584$10.08$6K
2026-02-11BDSXBIODESIX INCM — Option exercise1.6K—
2026-01-20BDSXBIODESIX INCS — Open-market sale298$8.15$2K
2026-01-20BDSXBIODESIX INCM — Option exercise805—
2025-08-12BDSXBIODESIX INCS — Open-market sale476$0.42$198
2025-08-12BDSXBIODESIX INCM — Option exercise1.5K—
2024-11-13BDSXBIODESIX INCS — Open-market sale224$1.40$314
2024-11-13BDSXBIODESIX INCS — Open-market sale238$1.39$331
2024-11-13BDSXBIODESIX INCM — Option exercise1.5K—

Frequently Asked Questions

Who is O'Kane Kieran?

Kieran O'Kane is the Chief Commercial Officer at Biodesix Inc, a company specializing in diagnostic solutions for lung disease. He has been involved in the company's operations as it provides diagnostic testing services and develops companion diagnostics.…

Has O'Kane Kieran been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 6 open-market sales ($16K) across all tracked filings.

Where can I see all of O'Kane Kieran's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live O'Kane Kieran profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.